CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Diogo Rau

EVP & Chief Information and Digital Officer, Lilly (Eli)

Verified interview transcripts, podcast appearances, and direct quotes from Diogo Rau, EVP & Chief Information and Digital Officer at Lilly (Eli). AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • Eli Lilly & The Future of Pharma AI | How AI Is Transforming Drug Discovery

    AI is redefining the future of healthcare — and pharma is at the center of the transformation. At #DellTechWorld Eli Lilly shares how AI infrastructure and intelligent systems are changing the speed and scale of innovation in medicine.

    Watch on YouTube ↗

  • Scaling enterprise AI: Fireside chat with Eli Lilly’s Diogo Rau and Dario Amodei

    Dario Amodei, CEO and co-founder at Anthropic, sits down with Diogo Rau, Chief Information and Digital Officer at Eli Lilly and Company, to discuss building enterprise AI for regulated industries like life sciences. In his role at Lilly, Diogo is responsible for setting the pharmaceutical leader’s AI strategy, including how organizations use models like Claude to power clinical research and drug development. The two discuss Anthropic’s approach to building more steerable and reliable AI for enterprise deployments, our commitment to creating more skills for life sciences use cases, and the…

    Watch on YouTube ↗

  • Pharma's Future: with Diogo Rau, Dan Priest, and Nicholas Thompson - MITIAI Episode 11

    How is AI shaping the future of healthcare? In this episode, Nicholas speaks with Eli Lilly’s Diogo Rau about how AI is making it easier and faster to find life-saving drugs, and PwC Chief AI Officer Dan Priest about how the technology will transform healthcare experiences for patients in the next decade. Featured Guests: Diogo Rau, Executive Vice President and Chief Information and Digital Officer at Eli Lilly & Dan Priest, Chief AI Officer at PwC

    Watch on YouTube ↗

  • The Future of Healthcare Technology with Eli Lilly and Company’s Diogo Rau | Curious Minds Gladwell

    ABOUT REVISIONIST HISTORY Revisionist History is Malcolm Gladwell’s journey through the overlooked and the misunderstood. Every podcast episode re-examines something from the past — an event, a person, an idea, even a song — and asks whether we got it right the first time. Because sometimes the past deserves a second chance. ABOUT MALCOLM GLADWELL Malcolm Gladwell is president and co-founder of Pushkin Industries. He is a journalist, a speaker, and the author of six New York Times bestsellers including The Tipping Point, Blink, Outliers, David and Goliath, and Talking to Strangers. He has bee…

    Watch on YouTube ↗

  • AI Opportunities in Pharma with Eli Lilly, AstraZeneca, & Bristol Myers Squibb | Technovation 880

    Few industries are as knowledge-centric as pharma and healthcare, where groundbreaking innovations can positively impact lives and potentially eradicate diseases. In this episode of Technovation, we feature a discussion from our May 2024 Metis Strategy Digital Symposium, where AstraZeneca CDO/CIO Cindy Hoots, Bristol Myers Squibb CDTO Greg Meyers, and Eli Lilly CIDO Diogo Rau explore the profound impact of artificial intelligence on talent management, research and development, and operational efficiencies within the pharma industry. These executives delve into the innovative applications of AI…

    Watch on YouTube ↗

  • Diogo Rau - Executive Vice President and Chief Information and Digital Officer - Eli Lilly & Company

    Diogo Rau is Executive Vice President and Chief Information and Digital Officer of Eli Lilly and Company ( https://www.lilly.com/leadership/exec... ) where he leads Lilly’s information technology, cybersecurity, digital health, and advanced analytics and data science functions. Mr. Rau also serves as Chair of PrescriberPoint ( https://prescriberpoint.com/ ), a digital marketplace, which Lilly was a seed investor in, where healthcare providers can find all of the resources and support they need in one place to get their patients on therapy, for any medication approved by the U.S. Food and Drug…

    Watch on YouTube ↗

  • Eli Lilly CIDO Diogo Rau on the Digital Acceleration of Drug Discovery | Technovation 648

    Diogo Rau, CIDO of Eli Lilly, discusses with Peter High the areas of opportunity in the drug discovery industry that technology has helped accelerate. He starts with his strategic priorities in his first year as CIDO and what attracted him to this complex industry. Diogo then expands upon the data strategy of the company and how machine learning is accelerating drug discovery. Finally, he talks about how he has harnessed the talent in the Indianapolis area, long-lasting changes from the pandemic, and the keys to success in Diogo’s diverse career. 0:00:00 Introduction 0:00:44 Diogo Rau's Purvi…

    Watch on YouTube ↗

Other executives at Lilly (Eli)

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →